Legend Biotech (LEGN) Enterprise Value (2019 - 2025)

Legend Biotech has reported Enterprise Value for 7 years, with the latest figure at -$286.7 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value changed 0.02% year-over-year to -$286.7 million; the trailing twelve-month figure through Dec 2025 stood at -$286.7 million (changed 0.02% YoY), and the FY2025 full-year result was -$286.7 million, changed 0.02% from the prior year.
• Enterprise Value for Q4 2025 stood at -$286.7 million, down from -$278.9 million in the prior quarter.
• The five-year high for Enterprise Value was -$243.5 million in Q2 2024, with the low at -$1.4 billion in Q2 2023.
• Historically, Enterprise Value has averaged -$649.0 million across 5 years, with a median of -$473.7 million in 2021.
• Annual changes were most pronounced in 2021 — Enterprise Value plunged 485.64% — and 2024, when it surged 82.84%.
• Legend Biotech's Enterprise Value stood at -$690.4 million in 2021, then plunged by 40.74% to -$971.6 million in 2022, then sank by 31.57% to -$1.3 billion in 2023, then surged by 77.57% to -$286.8 million in 2024, then climbed by 0.02% to -$286.7 million in 2025.
• The last three Enterprise Value figures came in at -$286.7 million (Q4 2025), -$278.9 million (Q3 2025), and -$266.7 million (Q2 2025), per Business Quant data.